These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 686544)

  • 41. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
    Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
    J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beneficial effect of aspirin on renal function post-cardiopulmonary bypass.
    Gerrah R; Izhar U
    Asian Cardiovasc Thorac Ann; 2003 Dec; 11(4):304-8. PubMed ID: 14681089
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of effect of prostaglandin inhibition on calcium excretion in normal volunteers.
    Rocco VK; Sakhaee K; Pak CY; Brater DC
    J Urol; 1985 Jun; 133(6):1093-4. PubMed ID: 3999216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal vasoactive hormones in scleroderma (progressive systemic sclerosis).
    Oliver JA; Vinci JM; Bowden RE; Weinberger AB; Baer L; Keiser HR; Cannon PJ
    Nephron; 1981; 29(3-4):110-6. PubMed ID: 7035981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of famotidine, a new histamine H2-receptor antagonist, on renal function.
    Ishigami M; Sezai Y; Shimada Y; Maeda T; Yabuki S
    Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):687-91. PubMed ID: 2571741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute renal effects of sulindac and indomethacin in chronic renal failure.
    Berg KJ; Talseth T
    Clin Pharmacol Ther; 1985 Apr; 37(4):447-52. PubMed ID: 3884224
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary mononuclear cell and disease activity of systemic lupus erythematosus.
    Chan RW; Lai FM; Li EK; Tam LS; Chung KY; Chow KM; Li PK; Szeto CC
    Lupus; 2006; 15(5):262-7. PubMed ID: 16761499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects.
    Golper TA; Noonan HM; Elzinga L; Gilbert D; Brummett R; Anderson JL; Bennett WM
    Clin Pharmacol Ther; 1988 May; 43(5):565-70. PubMed ID: 3365918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glomerular filtration rate measurement in cirrhotic patients with renal failure.
    Roy L; Legault L; Pomier-Layrargues G
    Clin Nephrol; 1998 Dec; 50(6):342-6. PubMed ID: 9877106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of local prostaglandin synthesis in the modulation of proliferative activity of rat colonic epithelium.
    Craven PA; Saito R; DeRubertis FR
    J Clin Invest; 1983 Oct; 72(4):1365-75. PubMed ID: 6313761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of short-term treatment with diclofenac-colestyramine on renal function and urinary prostanoid excretion in patients with type-2 diabetes.
    Farker K; Merkel U; Schweer H; Haerting J; Madani SF; Eggers R; Müller UA; Seyberth HW; Hoffmann A
    Eur J Clin Pharmacol; 2002 May; 58(2):85-91. PubMed ID: 12012138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversal by prostaglandin E2 infusion of the effects of indomethacin on the excretion of nitrogenous compounds in the rat.
    Rowe DJ; Gedeon G
    Br J Exp Pathol; 1983 Jun; 64(3):306-11. PubMed ID: 6576805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sequential pathophysiological changes characterizing the progression from renal dysfunction to acute renal failure following cardiac operation.
    Hilberman M; Derby GC; Spencer RJ; Stinson EB
    J Thorac Cardiovasc Surg; 1980 Jun; 79(6):838-44. PubMed ID: 7374199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites.
    Quintero E; Ginés P; Arroyo V; Rimola A; Camps J; Gaya J; Guevara A; Rodamilans M; Rodés J
    Nephron; 1986; 42(4):298-303. PubMed ID: 3515219
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urinary prostaglandin D synthase as biomarker in lupus nephritis: a longitudinal study.
    Gupta R; Yadav A; Misra R; Aggarwal A
    Clin Exp Rheumatol; 2015; 33(5):694-8. PubMed ID: 26211517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Organic acid secretory pathway and urinary excretion of prostaglandin E in the dog.
    Rosenblatt SG; Patak RV; Lifschitz MD
    Am J Physiol; 1978 Nov; 235(5):F473-9. PubMed ID: 727265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stimulation of renal prostaglandins by pressor hormones in man: comparison of prostaglandin E2 and prostacyclin (6 keto prostaglandin F1 alpha).
    Nadler J; Zipser RD; Coleman R; Horton R
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1260-5. PubMed ID: 6341391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of acetylsalicylic acid on urinary excretion of prostaglandin E in stroke patients.
    Lee TK; Hsieh BS
    Prostaglandins; 1986 Dec; 32(6):847-55. PubMed ID: 3562867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma prostaglandin E in patients with cancer with and without hypercalcemia.
    Robertson RP; Baylink DJ; Metz SA; Cummings KB
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1330-5. PubMed ID: 1002818
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Apalcillin and renal function].
    Fillastre JP; Moulin B; Josse S; Frelon JH
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):694-8. PubMed ID: 3054749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.